These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 37248764)

  • 61.
    Lu J; An SG; Ma JJ; Yang Y; Zhang L; Yu P; Tao H; Chen YF; Zhang HX
    Chin Med Sci J; 2022 Dec; 37(4):331-339. PubMed ID: 36647592
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Identification of lncRNA/circRNA-miRNA-mRNA ceRNA Network as Biomarkers for Hepatocellular Carcinoma.
    Chen S; Zhang Y; Ding X; Li W
    Front Genet; 2022; 13():838869. PubMed ID: 35386284
    [No Abstract]   [Full Text] [Related]  

  • 63.
    Cheng C; Wu X; Shen Y; Li Q
    Cancer Manag Res; 2020; 12():13241-13257. PubMed ID: 33380832
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Using Integrated Bioinformatics Analysis to Identify Abnormally Methylated Differentially Expressed Genes in Hepatocellular Carcinoma.
    Chen QL; Yan Q; Feng KL; Xie CF; Fang CK; Wang JN; Liu LH; Li Y; Zhong C
    Int J Gen Med; 2021; 14():805-823. PubMed ID: 33732011
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The upregulation of
    Cui Z; Wang J; Chen G; Li D; Cheng B; Lai Y; Wu Z
    Front Oncol; 2022; 12():1081510. PubMed ID: 36698420
    [TBL] [Abstract][Full Text] [Related]  

  • 66.
    Tan Z; Chen M; Peng F; Yang P; Peng Z; Zhang Z; Li X; Zhu X; Zhang L; Zhao Y; Liu Y
    Transl Cancer Res; 2022 Aug; 11(8):2713-2732. PubMed ID: 36093522
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The roles of the cell division cycle-associated gene family in hepatocellular carcinoma.
    Tao Q; Chen S; Liu J; Zhao P; Jiang L; Tu X; Tang X; Liu Z; Yasheng A; Tuerxun K; Zheng Y
    J Gastrointest Oncol; 2021 Apr; 12(2):781-794. PubMed ID: 34012666
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Identification of Hub Genes Associated With Immune Infiltration and Predict Prognosis in Hepatocellular Carcinoma via Bioinformatics Approaches.
    Chen H; Wu J; Lu L; Hu Z; Li X; Huang L; Zhang X; Chen M; Qin X; Xie L
    Front Genet; 2020; 11():575762. PubMed ID: 33505422
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Comprehensive analysis of ubiquitin-specific protease 1 reveals its importance in hepatocellular carcinoma.
    Zhao Y; Xue C; Xie Z; Ouyang X; Li L
    Cell Prolif; 2020 Oct; 53(10):e12908. PubMed ID: 32951278
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Overexpression of CISD1 Predicts Worse Survival in Hepatocarcinoma Patients.
    Lu T; Li C; Xiang C; Gong Y; Peng W; Chen C
    Biomed Res Int; 2022; 2022():7823191. PubMed ID: 35313629
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Aberrantly DNA Methylated-Differentially Expressed Genes and Pathways in Hepatocellular Carcinoma.
    Cai C; Wang W; Tu Z
    J Cancer; 2019; 10(2):355-366. PubMed ID: 30719129
    [No Abstract]   [Full Text] [Related]  

  • 72. Application of Molecular Nanoprobes in the Analysis of Differentially Expressed Genes and Prognostic Models of Primary Hepatocellular Carcinoma.
    Luo S; Gan L; Luo Y; Zhang Z; Li L; Wang H; Li T; Chen Q; Huang Y; He J; Zhong L; Liu X; Wu P; Wang Y; Zhao Y; Zhang Z
    J Biomed Nanotechnol; 2021 Jun; 17(6):1020-1033. PubMed ID: 34167617
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Differences of core genes in liver fibrosis and hepatocellular carcinoma: Evidence from integrated bioinformatics and immunohistochemical analysis.
    Li Y; Yuan SL; Yin JY; Yang K; Zhou XG; Xie W; Wang Q
    World J Gastrointest Oncol; 2022 Jul; 14(7):1265-1280. PubMed ID: 36051101
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Mining prognostic markers of Asian hepatocellular carcinoma patients based on the apoptosis-related genes.
    Yan J; Cao J; Chen Z
    BMC Cancer; 2021 Feb; 21(1):175. PubMed ID: 33602168
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Upregulation of Stress-Induced Protein Kinase CK1 Delta is associated with a Poor Prognosis for patients with Hepatocellular Carcinoma.
    Zhang H; Qiu C; Zeng H; Zhu W; Lyu W; Lao X
    Genet Test Mol Biomarkers; 2021 Jul; 25(7):504-514. PubMed ID: 34280005
    [No Abstract]   [Full Text] [Related]  

  • 76. Identification of CFHR4 associated with poor prognosis of hepatocellular carcinoma.
    Ding Q; Li H; Xu Z; Hu K; Ye Q
    Front Oncol; 2022; 12():812663. PubMed ID: 36338737
    [TBL] [Abstract][Full Text] [Related]  

  • 77. CircCCNB1 silencing acting as a miR-106b-5p sponge inhibited GPM6A expression to promote HCC progression by enhancing DYNC1I1 expression and activating the AKT/ERK signaling pathway.
    Liu YM; Cao Y; Zhao PS; Wu LY; Lu YM; Wang YL; Zhao JF; Liu XG
    Int J Biol Sci; 2022; 18(2):637-651. PubMed ID: 35002514
    [No Abstract]   [Full Text] [Related]  

  • 78. LncRNA CSMD1-1 promotes the progression of Hepatocellular Carcinoma by activating MYC signaling.
    Liu J; Xu R; Mai SJ; Ma YS; Zhang MY; Cao PS; Weng NQ; Wang RQ; Cao D; Wei W; Guo RP; Zhang YJ; Xu L; Chen MS; Zhang HZ; Huang L; Fu D; Wang HY
    Theranostics; 2020; 10(17):7527-7544. PubMed ID: 32685003
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Identification and validation of real hub genes in hepatocellular carcinoma based on weighted gene co-expression network analysis.
    Qiao Y; Yuan F; Wang X; Hu J; Mao Y; Zhao Z
    Cancer Biomark; 2022; 35(2):227-243. PubMed ID: 36120772
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Comprehensive analyses of competing endogenous RNA networks reveal potential biomarkers for predicting hepatocellular carcinoma recurrence.
    Yan P; Huang Z; Mou T; Luo Y; Liu Y; Zhou B; Cao Z; Wu Z
    BMC Cancer; 2021 Apr; 21(1):436. PubMed ID: 33879119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.